menu
    • menu

    Company profile for Polaryx Therapeutics

    NEW Drugs in Dev: 3
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Polaryx® Therapeutics, Inc is developing patient-friendly, orally-available, small molecule therapeutics for lysosomal storage disorders and neurodegenerative disorders. Polaryx’s® drugs enhance cellular clearance pathways to eliminate cellular waste.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Polaryx TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    South Tower, 140 E Ridgewood Ave Suite 415, Paramus, NJ 07652, United States
    Telephone
    Telephone
    +1-201-940-7236
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.polaryx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Polaryx777

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Fast-Tracks Polaryx's PLX-200 for Late-Infantile CLN2 Disease
    FDA Fast-Tracks Polaryx's PLX-200 for Late-Infantile CLN2 Disease

    17 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/17/3257171/0/en/Polaryx-Therapeutics-Receives-FDA-Fast-Track-Designation-for-PLX-200-for-Late-Infantile-Neuronal-Ceroid-Lipofuscinosis-CLN2-Disease.html

    GLOBENEWSWIRE
    17 Mar 2026
    Share Share
    Polaryx Therapeutics Strengthens Krabbe Disease Community
    Polaryx Therapeutics Strengthens Krabbe Disease Community

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3254643/0/en/Polaryx-Therapeutics-Deepens-Engagement-with-the-Krabbe-Disease-Community-Through-Scientific-and-Patient-Advocacy-Events.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    Polaryx Reaffirms Commitment to Rare Pediatric Disorders
    Polaryx Reaffirms Commitment to Rare Pediatric Disorders

    27 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/27/3246511/0/en/Polaryx-Therapeutics-Marks-Rare-Disease-Day-Reaffirming-Commitment-to-Patients-with-Rare-Pediatric-Lysosomal-Storage-Disorders.html

    GLOBENEWSWIRE
    27 Feb 2026
    Share Share
    Polaryx Pharma Chooses CRO For SOTERIA Ph2 Basket Trial
    Polaryx Pharma Chooses CRO For SOTERIA Ph2 Basket Trial

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239304/0/en/Polaryx-Therapeutics-Selects-Contract-Research-Organization-for-SOTERIA-Phase-2-Basket-Trial.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Polaryx Reveals SOTERIA Pre-Clinical Data At 22nd Worldsymposium
    Polaryx Reveals SOTERIA Pre-Clinical Data At 22nd Worldsymposium

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235320/0/en/Polaryx-Announces-Key-Pre-Clinical-Data-Related-to-SOTERIA-at-the-22nd-Annual-WORLDSymposium.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    Polaryx Therapeutics Welcomes Members of the Board of Directors
    Polaryx Therapeutics Welcomes Members of the Board of Directors

    05 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/05/3232994/0/en/Polaryx-Therapeutics-Welcomes-New-Members-of-the-Board-of-Directors.html

    GLOBENEWSWIRE
    05 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search